Efficacy and safety of high-dose cisplatin and cyclophosphamide with glutathione protection in the treatment of bulky advanced epithelial ovarian cancer

Selective Modification of Glutathione Metabolism

1983 • 1,272 citations

High-Dose Cisplatin in Hypertonic Saline

1984 • 335 citations

Chemotherapy of ovarian cancer

1998 • 303 citations

Role of cytoreductive surgical treatment in the management of advanced ovarian cancer.

1979 • 260 citations

Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy

1988 • 191 citations

The level and half‐life of glutathione in human plasma

1980 • 165 citations

Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin

1985 • 158 citations

Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drug

1989 • 155 citations

High-dose cisplatin with sodium thiosulfate protection.

1985 • 148 citations

Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO Stages III and IV) as measured by surgical end-staging (second-look operation)

1983 • 106 citations

High-dose cisplatin therapy in ovarian cancer.

1985 • 92 citations

Chemotherapy for advanced or recurrent gynecologic cancer

1987 • 85 citations

High-dose cisplatin administration without hypertonic saline: observation of disabling neurotoxicity.

1985 • 79 citations

High dose cisplatin compared with high dose cyclophosphamide in the management of advanced epithelial ovarian cancer (FIGO stages III and IV): report from the North Thames Cooperative Group.

1985 • 65 citations

Primary or delayed debulking surgery and chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide in stage III-IV epithelial ovarian carcinoma.

1986 • 62 citations

Phase I study of cis-diamminedichloroplatinum(II) administered as a constant 5-day infusion.

1980 • 56 citations

Nephrotoxicity of high-dose intracavitary cisplatin with intravenous thiosulfate protection

1985 • 52 citations

A Preliminary Clinical Experience with Reduced Glutathione as Protector against Cisplatin-Toxicity

1987 • 47 citations

Protective Effect of Reduced Glutathione against CIS-Dichlorodiammine Platinum (II)–Induced Nephrotoxicity and Lethal Toxicity

1983 • 44 citations

High-dose cisplatin for lung cancer.

1982 • 31 citations

Present optimal therapy in ovarian cancer

1986 • 11 citations

Cisplatin in Cancer Therapy: Optimization of Treatment Regimens and Toxicity Protection

1983 • 9 citations

A Clinical Study of Reduced Glutathione as a Protective Agent Against Cisplatin-Induced Toxicity

1988 • 8 citations

Experimental Approaches to Reducing Platinum Induced Kidney Toxicity

1988 • 6 citations

Deleted Work

1955 • 0 citations